PCK 6.25% 3.4¢ painchek ltd

EPAT General Discussion, page-740

  1. 140 Posts.
    lightbulb Created with Sketch. 28
    The 17th-20th is not far away for the National Alzheimers Conference and we are yet to hear of any results from Daffas' visit to Europe. Going on past form management don't dangle the carrot before making announcements, they just come out with it. Wouldn't want to be sitting out waiting for the first commercialisation news when I could take a position now.

    From the previous announcement, meetings are already penciled in with potential customers and that is only one week from now. A long lineup of industry professionals will be part of this conference which could only be seen as beneficial exposure for ePAT on the way to (successful) commercial rollout.

    Is there anyone who has doubts that this will fail to have the uptake? I don't. We are just around the corner from a sustainable business model. Then bring on those crying kiddies. (TGA/CE approved, fully funded, experienced management with low expenditure).

    IMO
 
watchlist Created with Sketch. Add PCK (ASX) to my watchlist
(20min delay)
Last
3.4¢
Change
0.002(6.25%)
Mkt cap ! $55.61M
Open High Low Value Volume
3.3¢ 3.6¢ 3.3¢ $52.72K 1.516M

Buyers (Bids)

No. Vol. Price($)
3 374964 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.5¢ 313761 3
View Market Depth
Last trade - 14.26pm 19/07/2024 (20 minute delay) ?
PCK (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.